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Multilevel versus isolated endovascular tibial
interventions for critical limb ischemia
Nathan Fernandez, MD, Ryan McEnaney, MD, Luke K. Marone, MD, Robert Y. Rhee, MD,
Steven Leers, MD, Michel Makaroun, MD, and Rabih A. Chaer, MD, Pittsburgh, Pa
Objective: Endovascular interventions for critical limb ischemia (CLI) continue to have variable reported results. The
purpose of this study is to determine the effect of disease level and distribution on the outcomes of tibial interventions.
Methods: A retrospective analysis of all tibial interventions done for CLI between 2006 and 2009 was performed.
Outcomes of isolated tibial (group I) andmultilevel interventions (group II) (femoropopliteal and tibial) were compared.
Results: Endovascular interventions were utilized to treat 136 limbs in 123 patients for CLI: 54 isolated tibial (85% tissue
loss), and 82multilevel (80% tissue loss). Mean age and baseline comorbidities were comparable. Themean ankle-brachial
index (ABI) was significantly lower prior to intervention in group II (0.53 vs 0.74; P < .001) but was similar
postintervention (0.86 vs 0.88; P  NS). Wound healing or improvement was achieved in 69% in group I and in 87% in
group II (P  .05). Mean overall follow-up was 12.6  5.3 months. Time to healing was significantly longer in group I:
11.5  8.8 months vs 7.7  6.6 months (P  .03). Limb salvage was achieved in 81% of group I and 95% of group II (P 
.05). The rate of reintervention was similar (13% vs 18%, P  NS), so was the rate of late surgical conversion (0% vs 6%;
P NS). Limb loss resulted from lack of conduit or initial target vessel for bypass and high-risk systemic comorbidities.
Overall mortality rates were similar among both groups. An isolated tibial intervention was a predictor of limb loss at 1
year on multivariate analysis and resulted in a lower rate of limb salvage at 1 year compared with multilevel interventions.
Additionally, despite comparable primary patency rates, there was improved secondary patency with multilevel interven-
tions compared with the isolated tibial interventions. Predictors of limb loss in patients treated with isolated tibial
intervention included multiple synchronous tibial revascularization (P  .005) and advanced coronary artery disease
requiring revascularization (P  .005).
Conclusions: Adequate rates of limb salvage can be achieved in patients undergoing multilevel interventions for CLI, and
improved patency is seen with multilevel compared to isolated tibial interventions. Patients with isolated tibial disease
appear to have a higher incidence of limb loss secondary to poor initial pedal runoff, more extensive distal disease, and
severe comorbidities precluding surgical bypass. Other therapeutic strategies should be considered in these patients,
including primary amputation or pedal bypass when applicable. ( J Vasc Surg 2011;54:722-9.)
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tPatients presenting with critical limb ischemia (CLI)
(rest pain and tissue loss, Rutherford category 4, 5, 6) have
been traditionally treated with surgical bypass, however,
advances in endovascular techniques, including subintimal
angioplasty, as well as technological advances have allowed
the successful treatment of more complex patterns of dis-
ease. This has resulted in a paradigm shift in the treatment
of CLI, and multiple series have reported on successful
percutaneous treatment of CLI at the femoral and popliteal
levels.1-3
Recommendations for the treatment of infrapopliteal
disease remain mixed, as the updated TransAtlantic Inter-
society Consensus (TASC) II guidelines state that for the
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722ndovascular treatment of infrapopliteal disease, angio-
lasty may be indicated for limb salvage and that the
reatment of tibial artery occlusion should be reserved for
ases in which in-line flow into the pedal vasculature can be
stablished.4 Additionally, while a diffuse disease distribu-
ion may be more challenging to treat percutaneously and
ay represent a more advanced plaque burden, improved
utcomes have been previously suggested for multilevel
ompared with isolated tibial interventions in terms of
atency.5 In an attempt to better define treatment algo-
ithms based on lesion extent and distribution, this study
ought to compare multilevel to isolated tibial interven-
ions and determine predictors of failure.
ETHODS
Patient population. All patients treated with an in-
rainguinal endovascular revascularization, which included
ibial artery endovascular interventions (TAEI) between
eptember 2006 and January 2009, were retrospectively
dentified from a physician database. Indications for treat-
ent included rest pain (Rutherford category 4) and/or
issue loss (Rutherford category 5/6). Patients who pre-
ented with acute ischemia or who were treated for claudi-
ation were excluded. Patient characteristics, comorbidi-
ies, intervention sites, and complications were recorded.
imbs were grouped based on the level of intervention
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Volume 54, Number 3 Fernandez et al 723performed: limbs treated with isolated TAEI constituted
group I (group I) and those undergoing multilevel inter-
ventions group II (group II). Clinical outcomes, including
primary patency, primary-assisted patency, secondary pa-
tency, limb salvage, and wound healing rates were deter-
mined for both groups.
Endovascular approach. All procedures were per-
formed by vascular surgeons using fixed-imaging under
local anesthesia with conscious sedation. Contralateral ret-
rograde common femoral access was most commonly per-
formed, whereas ipsilateral antegrade access or transbra-
chial access was selectively used. Interventions were
performed under systemic heparinization (100 U/kg). For
complete occlusions, it has been our practice to cross
femoropopliteal lesions in a subintimal plane given our
higher success rate compared with intraluminal techniques,
while an intraluminal recanalization was our first-line ap-
proach for tibial occlusions given the concerns of perfora-
tion and difficult reentry with subintimal techniques. Bal-
loon diameter was selected based on the angiographic
measurements of the nondiseased arterial segment proxi-
mal and distal to the lesion. Stenting of the origin of the
superficial femoral artery, the retro and infrageniculate
popliteal, and the tibials was generally avoided. In addition
to angioplasty and stenting, debulking of some tibial le-
sions was performed with laser atherectomy (Spectranetics
Corporation, Colorado Springs, Colo) at the discretion of
the operating surgeon. All interventions were performed
with the intention to treat all levels of disease with the
maximal tibial runoff in an attempt to obtain in-line flow to
the foot.
Definitions and classifications. Primary patency was
defined as the absence of restenosis or occlusion in the
treated arterial segment, and primary patency was lost if
there was a need for repeat endovascular intervention,
surgical bypass, or progression of tissue loss requiring am-
putation. Restenosis was determined on nonnvasive test-
ing, which confirmed recurrent disease (ankle-brachial in-
dex [ABI] decrease 0.15, dampened pulse volume
recordings [PVRs] or evidence of stenoses by duplex ultra-
sound scan), regardless of symptom status, and was con-
firmed on repeat angiography only in patients with recur-
rent symptoms or failure of wound healing. In patients with
noncompressible ABI, reliance on toe pressures and PVR
tracings was the norm. The duplex ultrasound criteria
utilized for the detection of a hemodynamically significant
restenosis in an arterial segment previously treated with
angioplasty were a peak systolic velocity (PSV) of 300
cm/s or a velocity ratio (Vr)3.0. The criteria utilized for
the detection of a significant (80%) in-stent femoropop-
liteal stenosis were PSV 275 cm/s and a Vr 3.5.6
Although there are no standard duplex criteria for the
classification of tibial stenoses, we have utilized a PSV of
300 cm/s and a peak stenotic velocity/prestenotic veloc-
ity ratio of 3.5 as indicators of a severe stenosis. Noninvasive
vascular laboratory surveillance was routinely performed on
all patients at 1 month, 3 months, and 6 months postpro-
cedure. Patients were then evaluated at 6-month intervals. gAssisted-primary patency was achieved via secondary
ndovascular interventions to treat restenoses involving the
riginally treated arterial segment. Additional procedures
o treat lesions proximal or distal to the initially treated
egment were also considered secondary interventions to
chieve primary-assisted patency. Secondary patency was
chieved utilizing reinterventions on occluded but previ-
usly treated arterial segments. Patients with initial isolated
ibial interventions who required later femoropopliteal in-
erventions were counted as part of the isolated tibial
roup, but lost primary patency at the time of femoropop-
iteal intervention in favor of primary-assisted patency.
Preintervention angiograms were reviewed and a TASC
lassification was assessed for the level of intervention.
ecause the updated TASC II guidelines do not include the
ibial runoff, the TASC I guidelines were utilized to assign
TASC classification to infrapopliteal lesions.7
Attempts were made to standardize the wound care
egimen. General principles included sharp excisional de-
ridement at each outpatient visit as needed, along with
opical outpatient wound care. If the wound appeared
nfected with signs of inflammation, systemic antibiotics
ere administered as well as topical antibiotic therapy.
nce the infection was cleared, routine wound care was
esumed. Our preferred wound measurement is the wound
urface area (measured as minor axis  major axis  0.8).
owever, exact measurements were not always docu-
ented, and changes in wound size were often obtained
rom the follow-up notes by the treating surgeon describ-
ng the wound as smaller/improved, larger/worse, or un-
hanged.
Statistical analysis. An independent statistician per-
ormed all advanced statistical analyses. Count data were
ummarized as frequencies and continuous variables as
eans standard deviations. One-year cumulative primary
atency, primary-assisted patency, secondary patency and
imb salvage were calculated by the Kaplan-Meier ap-
roach. Multivariable Cox proportional hazards regression
as used to develop predictive models.
ESULTS
Endovascular interventions were performed on 136
imbs in 123 patients, all for CLI. Overall the mean age was
4  11.3 years, and 62% of patients were male. Demo-
raphics and baseline comorbidities were comparable be-
ween the two groups (Table I). The overall mean
ollow-up was 12.6  5.3 months. A total of four patients
ere lost to follow-up.
All patients had a tibial artery intervention with or
ithout a more proximal intervention. There were 54 limbs
reated in group I, 85% of which were for tissue loss
Rutherford category 5/6 disease); 82 limbs were treated
n group II, 79% for tissue loss (P  .58) (Table II).
reintervention, the mean ABI was significantly lower in
roup II (0.53 vs 0.74; P  .001) but was similar between
he two groups postintervention (0.86 vs 0.88; P  NS).
he lesion TASC classifications for limbs treated in both
roups were similar and are presented in Table III.
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September 2011724 Fernandez et alOverall periprocedural complications included groin
hematoma (2.2%), pseudoaneurysm formation (0.7%), and
transient acute renal failure (0.7%). The overall 30-day
mortality rate was 2.5%. The rates of morbidity and mor-
tality between the two groups were similar (PNS) (Table
IV). A total of three patients died within 30 days of their
procedure. One patient died in group I from multiple
medical problems unrelated to her procedure and was
readmitted 2 weeks postprocedure with pneumonia and
sepsis. She went on to expire from multisystem organ
failure. In group II, one patient died from complications of
a groin hematoma after antegrade access requiring opera-
tive repair and developed multisystem organ failure, with
ultimate withdrawal of support and death. The other death
in group II was secondary to overwhelming sepsis related to
a peripherally-inserted central catheter line placed 3 weeks
postprocedure. Twenty patients died during the study from
unrelated causes, namely coronary disease and malignancy.
Wound healing. Of the limbs treated for tissue loss,
Table I. Demographic data and comorbidities of patients
Group I (n)
Mean age (years) 72.6  11.3 (73, 49-9
Male 65% (32)
Diabetes mellitus 65% (32)
Chronic renal insufficiency 55% (27)
ESRD/dialysis 20% (10)
Hypertension 94% (46)
Statin use 60% (29)
Prior CABG 32% (15)
Coronary artery disease 68% (32)
Congestive heart failure 36% (17)
History of MI 38% (17)
COPD 19% (9)
Cancer 13% (6)
History of tobacco use 49% (23)
Smoking status
Never 51% (24)
Former 38% (18)
Current 11% (5)
CABG, Coronary artery bypass graft; COPD, chronic obstructive pulmonar
artery endovascular interventions.
Table II. Indications for intervention, and wound type
and location among group I and group II
Group I (n) Group II (n) P value
Indication: NS
Gangrene 46% (25) 28% (23)
Ulcer 39% (21) 51% (42)
Rest pain 15% (8) 21% (17)
Wound type NS
Gangrene 54% (25) 65% (42)
Ulcer 46% (21) 35% (23)
Wound location NS
Forefoot 80% (37) 75% (49)
Heel 15% (7) 19% (12)
Ankle 2.2% (1) 6% (4)
Missing 2.2% (1)there was a trend toward better wound healing in the oultilevel intervention group (group II). Wounds were
ealed or improved at last follow-up in 69% of the limbs
reated in group I compared with 87% in the limbs treated
n group II (P  .055). In addition, the mean time to
omplete healing was significantly longer in group I;
4.6  8.1 months compared with 9.8  7.2 months in
roup II (P  .02) (Table V).
A logistic regression model was also constructed to
etermine the effect of wound type, wound location, and
ASC I tibial lesion classification on wound healing. The
rgoing TAEI
Group II (n) P value
74.9  11.4 (77.5, 50-95) NS
60% (44) .28
66% (49) .51
51% (37) .92
19% (14) .63
92% (67) .87
66% (46) .74
36% (26) .56
69% (50) .68
40% (27) .88
39% (24) 1
19% (12) .87
10% (7) .97
53% (36) .67
46% (31)
43% (29)
12% (8)
se; ESRD, end-stage renal disease; MI, myocardial infarction; TAEI, tibial
able III. Lesion classification and hemodynamic data
Group I
(n  54)
Group II
(n  81) P value
esion characterization
TASC II
Femoral and
popliteal
A NA 4.2% (3)
B NA 33.3% (27)
C NA 31.9% (26)
D NA 30.6% (25)
TASC I
Tibial lesions
A 0% (0) 1% (1)
B 6% (3) 5% (4)
C 41% (22) 42% (34)
D 54% (29) 52% (42)
emodynamic data
ABI
Preprocedure 0.74  0.23 0.53  0.24 .001
Postprocedure 0.88  0.25 0.86  0.20 .63
oe pressure (mm Hg)
Preprocedure 34.9  26.5 21.5  23.6 .2
Postprocedure 55.1  45.3 64.9  38.3 .57
BI, Ankle-brachial index; TASC, TransAtlantic Intersociety Consensus.unde
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with heel wounds compared with forefoot lesions (P 
.064) (Table VI).
Limb salvage. There were a total of 13 major ampu-
tations: 11 below the knee and two above the knee. The
overall limb salvage at the latest follow-up was significantly
higher in group II and was achieved in 95% of limbs
compared with a limb salvage rate of 81% in group I (P 
.05). In addition, isolated tibial interventions were predic-
tive of limb loss, on multivariate analysis. Life table analysis
also showed a significantly lower rate of limb salvage at 9
months and 1 year in group I compared with group II (P
.05) (Fig 1). Predictors of limb loss in patients in group I
includedmultiple synchronous tibial revascularization (P
Table IV. Perioperative data and complications
All interventions
(n)
Hematoma 2.2% (3)
Pseudoaneurysm 0.7% (1)
Vessel thrombosis 0% (0)
Renal failure 0.7% (1)
MI 0% (0)
Bleeding requiring surgery 2.2% (3)
Death 2.5% (3)
Mean length of stay (d) 3.0  5.3 (1, 0-40)
ICU admission 3.7% (5)
Table V. Wound healing
Wound healing All patients (n  136)
Isola
Healed or improved 80% (99)
Healed 46.0% (57)
Improved 33.9% (42)
Worse 4.0% (5)
Amputation 10.5% (13)
No change 5.6% (7)
Time to healing (mo)
Healed (n  57) 11.6  7.9 (11.5, 0-30.2) 14.6
Table VI. Effect of wound type, wound location, and
TASC I classification as predictors of wound healing
Characteristic
Odds
ratio 95% CI
P
value
Ulcer vs gangrene 1.26 0.54-2.93 .59
Heel vs forefoot (overall) 1.54 0.59-4.07 .38
Heel vs forefoot
(multilevel
intervention) 3 0.94-9.57 .06
Heel vs forefoot (tibial
intervention) 0.37 0.07-2.01 .25
TASC I C/D vs A/B lesions 0.72 0.13-4.02 .7
TASC I D vs A/B/C lesions 0.72 0.33-1.53 .39
TASC, TransAtlantic Intersociety Consensus..005) and advanced coronary disease requiring revascular- ezation (P .005). There was an association between renal
nsufficiency and limb loss, although this did not reach
tatistical significance (P  .06). Limb salvage was also
nalyzed by wound type, location, and extent of tibial
esions treated (TASC I). Wound type and/or location
ere not predictive of limb loss. Surprisingly, treatment of
ore extensive TASC C and D lesions was found to be
redictive of limb salvage compared with TASC A and B
esions treated, although a limited number of patients
three in group I, five in group II) were classified as TASC
or B (Table VII). This has to be interpreted with caution
iven the small number of patients with TASC A and B
esions and the likelihood of a type II error. Other variables
Multilevel
erventions (n)
Isolated tibial
interventions (n) P value
2.5% (2) 1.8% (1) NS
1.2% (1) 0% (0) NS
0% (0) 0% (0) —
1.2% (1) 0% (0) NS
0% (0) 0% (0) —
2.5% (2) 1.8% (1) NS
2.7% (2) 2.1% (1) NS
5.7 (1, 0-40) 2.8  4.7 (1, 0-18) NS
3.7% (3) 3.7% (2) NS
bial interventions
n  54)
Multilevel interventions
(n  82) P value
69% (33) 87% (66) .055
.8% (22) 46.0% (35) NS
.9% (11) 40.8% (31) .05
.2% (2) 3.9% (3) NS
.7% (9) 5.3% (4) .05
.3% (4) 3.9% (3)
.1 (13.9, 0-30.2) 9.8  7.2 (9.0, 0.25-27.0) .02
Fig 1. Cumulative limb salvage by type of intervention.int
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as well as antiplatelet therapy.
Patency rates. Analysis of patency for all limbs under-
going TAEI at 12 months showed a primary patency rate of
37%, a primary-assisted patency rate of 54%, and a second-
ary patency rate of 63% (Fig 2). Patency rates were compa-
rable between both groups at 1 year by Kaplan-Meier
analysis, with primary patency rates of 37% in group I vs
38% in group II (P .42) (Fig 3). There was a trend toward
Table VII. Effect of wound type, wound location, and
TASC I classification as predictors of limb loss
Characteristic
Hazard
ratio 95% CI P value
Ulcer vs gangrene 0.81 0.27-2.49 .72
Heel vs forefoot 1.54 0.41-5.82 .52
TASC I C/D vs A/B
lesions 0.16 0.03-0.74 .019
TASC I D vs A/B/C
lesions 0.94 0.35-2.50 .89
TASC, TransAtlantic Intersociety Consensus.
Fig 2. Patency rates for all limbs undergoing tibial artery endo-
vascular intervention.
Fig 3. Cumulative primary patency for group I and group II.improved primary-assisted patency for group II compared rith isolated TAEI (58% vs 52%) (P .09) (Fig 4), but the
econdary patency rates were significantly better for limbs
ndergoing multilevel interventions, 65% vs 58% (P 
046) (Fig 5).
Reinterventions. In the course of follow-up, a total of
9 patients (10 in group I and 29 in group II) underwent a
eintervention, with the most common indications, includ-
ng failure of wound healing and duplex ultrasound evi-
ence of recurrent severe stenosis in a treated segment
Table VIII). The characteristics and indications for repeat
ntervention are summarized in Table IX. Reinterventions
ere multilevel in both groups, as some patients in group I
ig 4. Cumulative primary-assisted patency for group I and
roup II.
Fig 5. Cumulative secondary patency for group I and group II.
able VIII. Indication for repeat endovascular
nterventions
ndication
Group I
(n  10)
Group II
(n  29)
ailure of wound healing 60% (6) 48% (14)
uplex evidence of recurrence 20% (2) 31% (9)
ecurrent ulceration NA 7% (2)
ecurrent rest pain 20% (2) 14% (4)equired femoral or popliteal interventions in addition to
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Volume 54, Number 3 Fernandez et al 727tibial reinterventions. Additionally, a total of eight patients
went on to require surgical bypass (five in group I and three
in group II) and their outcomes are summarized in Table X.
DISCUSSION
Endovascular treatment of CLI has become the first-
line approach in many centers.2,5,8 However, despite the
fact that tibial interventions for CLI have been extensively
described, results have been inconclusive with no clear
definition of which patients represent the best anatomic
and physiological candidates.1,9 A recent meta-analysis by
Romiti et al of infrapopliteal angioplasty for the treatment
of CLI showed an overall primary patency and secondary
patency rates of 58% and 68%, respectively, at 1 year, with a
limb salvage rate of 86% and patient survival of 98%.10
However, this study did not look at the wound healing as
an endpoint of TAEI. In the current series, 80% of patients
who were treated for tissue loss either healed or had im-
provement in their wounds. When comparing multilevel
interventions with isolated tibial interventions, there was a
strong trend toward complete or improved wound healing
in group II (87%) vs 69% in group I (P  .055). Although
there was no difference between the two treatment groups
in the rates of complete wound healing, the time to wound
healing was significantly longer (14.6 months vs 9.8
months) in the isolated tibial group compared with the
multilevel intervention group (P  .02). A possible expla-
nation to such findings include the fact that patients who
undergo an isolated tibial intervention may have a greater
local disease burden, which would increase the chance of
Table IX. Summary of repeat interventions by level
treated, type of intervention, and type of patency
Primary-assisted
patency
Secondary
patency
Level of intervention
Group I (n  7) (n  3)
Superficial femoral artery NA NA
Popliteal artery 14% (1) NA
Original tibial vessel 100% (7) 100% (3)
Alternate tibial vessel 29% (2) NA
Group II (n  18) (n  11)
Iliac 6% (1) NA
Superficial femoral artery 56% (10) 36% (4)
Popliteal artery 44% (8) 73% (8)
Original tibial vessel 72% (13) 91% (10)
Alternate tibial vessel 17% (3) 9% (1)
Type of intervention
Group I
Angioplasty 100% (7) 100% (3)
Laser atherectomy 14% (1) NA
Stenting NA NA
Group II
Angioplasty 94% (17) 100% (11)
Laser atherectomy 11% (2) 9% (1)
Silverhawk atherectomy NA 9% (1)
Stenting (fem pop) 33% (6) 55% (6)
Cryoplasty 11% (2) NArecurrence and limit the effectiveness of single-level inter- Oention. Alternatively, isolated tibial disease may represent
different, more aggressive disease process with more
requent small vessel disease and poorer outflow, although
e have noted a similar proportion of diabetic patients in
oth treatment groups. Wound healing was not included in
recent report by Sadek et al, but they also reported trends
oward improved limb salvage and primary patency as well
s significantly improved secondary patency when multi-
evel interventions involving the tibial vessels were com-
ared with isolated tibial artery interventions.5
Similar to our previously reported outcomes with TAEI
or CLI,11 all of the limbs in this series were treated for rest
ain or tissue loss. In the current study, an isolated tibial
ntervention and multiple synchronous tibial interventions
ere predictive of limb loss, and a multilevel intervention
as associated with improved limb salvage at 1 year. These
ndings can also be explained by a more aggressive local
isease burden in patients with isolated tibial disease. In
ddition, the treatment of TASC C and D tibial lesions was
ssociated with a lower rate of limb loss. This finding is
ikely related to the small numbers of TASC A and B lesions
reated, limiting the power of a comparative analysis. We
ere not able to find a significant difference in limb salvage
ased on wound location, heel vs forefoot, or the type of
ound treated, ulcer vs gangrene. In addition, although we
elieve that wound size on presentation is potentially an
mportant predictor of limb salvage, we were not able to
etrospectively obtain enough data on wound size to per-
orm any meaningful analysis of the effect of the amount of
issue loss on the effectiveness of TAEI for wound healing.
In the report by Sadek et al, a limb salvage rate of 81%
t 12 months was reported, which is similar to our study.
dditionally, they did have a trend toward improved limb
alvage with multilevel interventions but felt that their
tudy was underpowered to detect a true difference.5 Our
esults are also comparable to those reported by Giles et al
or CLI. They noted a limb salvage rate of 84% at 12
onths,12 which was similar to limb salvage rates with
ypass reported in the Prevent III trial (88% at 1 year).13
here were no instances of limb loss as a consequence of an
ndovascular intervention or periprocedural complication
n this series. Although all attempts at limb salvage were
ade, some patients did require a major amputation for
issue loss after they were offered a last effort endovascular
ntervention. Such patients typically have challenging ad-
anced cardiac comorbidities and/or inadequate pedal tar-
et vessel or saphenous or arm vein conduit for bypass.
In addition to improved limb salvage and reduced time
o healing with multilevel interventions, our current series
dentified improved patency in the multilevel cohort when
ompared with isolated tibial interventions. Although the
rimary patency rates were similar, we did see a trend
oward improved primary-assisted patency and did find a
ignificantly improved secondary patency with multilevel
nterventions. This is similar to findings described by Sadek
t al5 However, they did report improved primary pa-
ency with multilevel vs isolated tibial disease at 1 year.
ne possible explanation for this discrepancy is that
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4 to 6, 25% of the limbs treated in the report by Sadek et
al were  Rutherford 4.
The primary limitation of this report is inherent to its
retrospective nature. This included incomplete data avail-
able for wound-healing analysis. Additionally, the approach
to treatment of CLI was left to the discretion of the
operating surgeon. As such, there was no standard ap-
proach to the types of revascularization modality per-
formed. Although most patients were treated as part of an
“endo first” approach, some were referred for an endovas-
cular revascularization because of the lack of a bypass
target, lack of adequate vein conduit, or severe comorbidi-
ties precluding surgery. As such, this has resulted in a
heterogenous patient population with different comorbidi-
ties and disease distribution.
Finally, longer follow-up is essential and ongoing to
determine the durability of TAEI. This is particularly im-
portant in patients with tissue loss treated with TAEI since
longer follow-up is often needed to achieve complete
wound healing. As such, favorable wound outcomes may
not be reflected in patients with short, yet ongoing follow-
up.14 A prospective cohort is therefore needed to compare
the effectiveness of the different available endovascular
techniques and their impact on wound healing and limb
salvage. Nevertheless, based on the current data, patients
with CLI, even when presenting with tissue loss, should not
be denied endovascular revascularization in the setting of
diffuse multilevel disease distribution. In fact, such patients
seem to achieve better limb salvage andwound healing than
patients with isolated tibial disease.
CONCLUSIONS
Tibial artery endovascular intervention results in ac-
ceptable rates of limb salvage and wound healing with
appropriate wound care in patients undergoing multilevel
interventions for CLI, despite low patency rates at 1 year.
Patients with isolated tibial disease appear to have a higher
incidence of limb loss secondary to poor initial pedal runoff
Table X. Summary of patients requiring subsequent bypas
Patient Initial intervention
Group I
1 PTA PT
2 PTA PT
3 PTA peroneal
4 Laser atherectomy and PTA peroneal
5 PTA AT
Group II
1 PTA Pop, TPT, and peroneal
2 PTA/stent SFA, atherectomy and
PTA TPT/peroneal
3 PTA SFA, TPT, and peroneal
AKA, Above-knee amputation; AT, anterior tibial artery; Pop, popliteal arte
transmetatarsal amputation.and more extensive local disease. Other therapeutic strate-ies should be considered in these patients, including pedal
ypass if fit enough for bypass.
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